Search

Search Constraints

You searched for: Author/Creator Brooks, William S.

Search Results

1. Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. Issue 5 (13th October 2022)

3. Biomarker clustering in autosomal dominant Alzheimer's disease. Issue 1 (1st April 2022)

4. Characterization of amyloid‐related imaging abnormality in the DIAN‐TU‐001 trial. (31st December 2021)

5. Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies. Issue 1 (22nd February 2019)

6. Confirming Pathogenicity of the F386L PSEN1 Variant in a South Asian Family With Early-Onset Alzheimer Disease. (7th February 2022)

7. Confirming Pathogenicity of the F386L PSEN1 Variant in a South Asian Family With Early-Onset Alzheimer Disease. (7th February 2022)

8. Confirming Pathogenicity of the F386L PSEN1 Variant in a South Asian Family With Early-Onset Alzheimer Disease. (February 2022)

10. Gantenerumab in‐depth outcomes: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020)